Latin America Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Latin Americas Blood Glucose Test Strip Packaging Market Growth & Trends and the Market is Segmented Into Type (self-Monitoring Blood Glucose Devices (glucometer Devices, Test Strips, And Lancets) and Continuous Glucose Monitoring Devices (sensors and Durables (receivers and Transmitters))), And Geography (Mexico, Brazil, And Rest of Latin America). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

Latin America Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Latin America Blood Glucose Monitoring Market Size

View Global Report
Latin America Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 1.05 Billion
Market Size (2030) USD 1.52 Billion
CAGR (2025 - 2030) 7.82 %

Major Players

Latin America Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Latin America Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Latin America Blood Glucose Monitoring Market Analysis

The Latin America Blood Glucose Monitoring Market size is estimated at USD 1.05 billion in 2025, and is expected to reach USD 1.52 billion by 2030, at a CAGR of 7.82% during the forecast period (2025-2030).

The COVID-19 pandemic has substantially impacted the Latin America Blood Glucose Monitoring Market. People with diabetes have a weak immune system so, with COVID-19, the immune system gets weaker very fast. People with diabetes will have more chances to get into serious complications rather than normal people. The manufacturers of diabetes care devices have taken care during COVID-19 to deliver the diabetes care devices to diabetes patients with the help of local governments. Doctors around the world suggested diabetes patients should check their diabetes levels more often to be careful, which leads to an increase in the usage of diabetes care devices.

The COVID-19 pandemic has been testing the capacity to respond and adapt to populations, governments, and health systems worldwide. Brazil presented the first suspected and the first confirmed case in the Latin America region. Most Latin American countries failed to implement timely measures to protect individuals with diabetes, which severely impacted individuals, health systems, and economies.

The diabetic prevalence is high in countries in the Latin American region, and Mexico is known to have a high number of diabetic patients due to the growing prevalence of Type-2 diabetes in the country. The gradually growing obesity rate, combined with the genetic predisposition for Type-2 diabetes, acted as a prominent driver for the increase in the Type-2 diabetic population over the last 40 years. Currently, close to 10% of the total population is living with diabetes. Diabetic patients in the Latin American region mainly suffer from Type-2 diabetes, and they accounted for close to 90% of the total diabetic population.

According to IDF Diabetes Atlas, 15.7 million adults, about 10.5%, had diabetes in Brazil. The cost of diabetes-related health expenditure in Brazil is the third highest in the world. In addition, 18 million adults include Impaired Glucose Tolerance, which places them at high risk of developing type 2 diabetes. Additional data on glycemic control in Brazil show that only 25% met the therapeutic goal of glycated hemoglobin (HbA1c) less than 7% before the pandemic, as recommended by the Brazilian Diabetes Society.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Latin America Blood Glucose Monitoring Industry Overview

The Latin America Blood Glucose Monitoring Market is fragmented. Major players like Dexcom, Medtronic, and Abbott dominate the CGM devices market. The market for SMBG devices comprises key manufacturers like Roche, LifeScan, Arkray, Ascensia, etc., and other regional players.

Latin America Blood Glucose Monitoring Market Leaders

  1. Roche Diabetes Care

  2. Abbott Diabetes Care

  3. Medtronic PLC

  4. Dexcom Inc.

  5. LifeScan Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Latin America Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Latin America Blood Glucose Monitoring Market News

  • January 2024: Medtronic plc announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) requiring no fingersticks or overtape. Simplera Sync features an improved user experience with a simple, two-step insertion process and is half the size of previous Medtronic sensors.
  • August 2022: Abbott and WW International, Inc. (WeightWatchers) announced a strategic partnership to help people with diabetes better understand and manage their diabetes and weight. The companies are working to integrate WeightWatchers' diabetes-tailored weight management program with Abbott's portfolio of FreeStyle Libre products. It is to create a seamless mobile experience that will give people living with diabetes the information and insights needed to make healthy adjustments to their diet, improve their glucose levels, and, ultimately, gain more control of their health.

Latin America Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)
  • 5.3 Geography
    • 5.3.1 Mexico
    • 5.3.2 Brazil
    • 5.3.3 Rest of Latin America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan Inc.
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Medisana AG
    • 7.1.12 Trivida Functional Medicine
    • 7.1.13 Rossmax International Ltd.
    • 7.1.14 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.1.4 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care
    • 7.2.2.4 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*The report covers a segment-wise breakdown (Value and Volume) for all the countries covered under Table of Contents **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Latin America Blood Glucose Monitoring Industry Segmentation

Blood Glucose Monitoring Devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients. The Latin America Blood Glucose Monitoring Market is segmented into type, and geography. The report offers the value (in USD) and volume (in units) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Geography Mexico
Brazil
Rest of Latin America
Need A Different Region or Segment?
Customize Now

Latin America Blood Glucose Monitoring Market Research FAQs

How big is the Latin America Blood Glucose Monitoring Market?

The Latin America Blood Glucose Monitoring Market size is expected to reach USD 1.05 billion in 2025 and grow at a CAGR of 7.82% to reach USD 1.52 billion by 2030.

What is the current Latin America Blood Glucose Monitoring Market size?

In 2025, the Latin America Blood Glucose Monitoring Market size is expected to reach USD 1.05 billion.

Who are the key players in Latin America Blood Glucose Monitoring Market?

Roche Diabetes Care, Abbott Diabetes Care, Medtronic PLC, Dexcom Inc. and LifeScan Inc. are the major companies operating in the Latin America Blood Glucose Monitoring Market.

What years does this Latin America Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Latin America Blood Glucose Monitoring Market size was estimated at USD 0.97 billion. The report covers the Latin America Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Latin America Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Latin Americas Blood Glucose Monitoring Industry Report

Statistics for the 2025 Latin America Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Latin America Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.